GBGB1917863.1A
GB201917863D0
(en)
|
2019-12-06 |
2019-12-06 |
Novel compounds
|
TW109126865A
TW202120486A
(en)
|
2019-08-09 |
2020-08-07 |
Novel compounds
|
MX2022001690A
MX2022001690A
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer.
|
DK20754011.3T
DK4010329T3
(en)
|
2019-08-09 |
2020-08-10 |
DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
|
PL20754011.3T
PL4010329T3
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
AU2020327661A
AU2020327661A1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
HUE20754011A
HUE063145T2
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
JP2022507895A
JP2022544211A
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compound for use in treating cancer
|
LTEPPCT/GB2020/051901T
LT4010329T
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
RS20230694A
RS64486B1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
SI202030260T
SI4010329T1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
KR1020227007755A
KR20220050148A
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated Compounds for Use in Cancer Treatment
|
PCT/GB2020/051901
WO2021028670A1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
CA3149119A
CA3149119A1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
BR112022002496A
BR112022002496A2
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
HRP20231037TT
HRP20231037T1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
PT207540113T
PT4010329T
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
CN202080070533.0A
CN114846003A
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for the treatment of cancer
|
EP20754011.3A
EP4010329B9
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
FIEP20754011.3T
FI4010329T3
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
US17/597,957
US20220259174A1
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in the treatment of cancer
|
ES20754011T
ES2952281T3
(en)
|
2019-08-09 |
2020-08-10 |
Deuterated compounds for use in cancer treatment
|
ZA2022/01364A
ZA202201364B
(en)
|
2019-08-09 |
2022-01-28 |
Deuterated compounds for use in the treatment of cancer
|
IL290415A
IL290415A
(en)
|
2019-08-09 |
2022-02-07 |
Deuterated compounds for use in the treatment of cancer
|